India to Nigeria: Vaccine Export Trade Route

The India to Nigeria Vaccine corridor is one of India's established pharmaceutical export routes, with 530 shipments documented worth a combined $84.5M USD. The route is dominated by BIOLOGICAL E. LIMITED, which alone accounts for roughly 18% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.

Across 29 active suppliers, the average shipment value stands at $159.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with vaccine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #1 among India's top vaccine export destinations globally.

On the import side, key buyers of Indian vaccine in Nigeria include NATIONAL PRIMARY HEALTH CARE , NATIONAL PRIMARY HEALTH CARE, NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY NPHCDA and 41 others. NATIONAL PRIMARY HEALTH CARE is the single largest importer with 45 shipments valued at $27.7M USD.

India's vaccine exports to Nigeria are driven primarily by a handful of large-scale manufacturers. BIOLOGICAL E. LIMITED with 38 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 29 active exporters signals a competitive but concentrated market — buyers in Nigeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BIOLOGICAL E. LIMITED, SERUM INSTITUTE OF INDIA PRIVATE LIMITED, SANOFI HEALTHCARE INDIA PRIVATE LIMITED — together account for 49% of total trade value on this route. The average shipment value of $159.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rotavac 5 ml rotavirus vaccine (live ora and dtp-hepb-hib (pentavalent vaccine) fullyliquid combination vaccine 10 dose vialpaediaric dose diphtheria,tetanus,**, suggesting that buyers in Nigeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NATIONAL PRIMARY HEALTH CARE is the largest importer with 45 shipments worth $27.7M USD — representing 33% of all vaccine imports from India on this route. A total of 44 buyers are active on this corridor.